These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35536548)

  • 81. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
    Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
    Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ergosterol analogs as inhibitors of cyclin dependent kinase 8.
    Siapkaras PD; Solum EJ
    Steroids; 2022 Feb; 178():108965. PubMed ID: 35065996
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapeutic potential of carbon monoxide (CO) for intestinal inflammation.
    Naito Y; Uchiyama K; Takagi T; Yoshikawa T
    Curr Med Chem; 2012; 19(1):70-6. PubMed ID: 22300078
    [TBL] [Abstract][Full Text] [Related]  

  • 84. New drugs on the horizon for IBD.
    Sands BE
    Dig Dis; 2014; 32 Suppl 1():74-81. PubMed ID: 25531356
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Natural products as a source of anti-inflammatory agents associated with inflammatory bowel disease.
    Debnath T; Kim DH; Lim BO
    Molecules; 2013 Jun; 18(6):7253-70. PubMed ID: 23783459
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.
    Laverny G; Penna G; Vetrano S; Correale C; Nebuloni M; Danese S; Adorini L
    Immunol Lett; 2010 Jun; 131(1):49-58. PubMed ID: 20350569
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease.
    Seo DH; Che X; Kwak MS; Kim S; Kim JH; Ma HW; Kim DH; Kim TI; Kim WH; Kim SW; Cheon JH
    Sci Rep; 2017 Apr; 7(1):851. PubMed ID: 28404987
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease.
    Yang T; Cui X; Tang M; Qi W; Zhu Z; Shi M; Yang L; Pei H; Zhang W; Xie L; Xu Y; Yang Z; Chen L
    J Med Chem; 2022 Feb; 65(4):3151-3172. PubMed ID: 35113547
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The novel piperazino-enaminone JOAB-40 reduced colitis severity in mice via inhibition tumor necrosis factor-α and interleukin-1β.
    Khajah MA; Hawai S; Szollosi DE; Bill A; Ghoneim O; Edafiogho I
    Biomed Pharmacother; 2021 Sep; 141():111852. PubMed ID: 34198045
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A precisely positioned MED12 activation helix stimulates CDK8 kinase activity.
    Klatt F; Leitner A; Kim IV; Ho-Xuan H; Schneider EV; Langhammer F; Weinmann R; Müller MR; Huber R; Meister G; Kuhn CD
    Proc Natl Acad Sci U S A; 2020 Feb; 117(6):2894-2905. PubMed ID: 31988137
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo.
    Tanimoto A; Ogawa Y; Oki C; Kimoto Y; Nozawa K; Amano W; Noji S; Shiozaki M; Matsuo A; Shinozaki Y; Matsushita M
    Inflamm Res; 2015 Jan; 64(1):41-51. PubMed ID: 25387665
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ichnocarpus frutescens (L.) R. Br. root derived phyto-steroids defends inflammation and algesia by pulling down the pro-inflammatory and nociceptive pain mediators: An in-vitro and in-vivo appraisal.
    Das N; Bhattacharya A; Kumar Mandal S; Debnath U; Dinda B; Mandal SC; Kumar Sinhamahapatra P; Kumar A; Dutta Choudhury M; Maiti S; Palit P
    Steroids; 2018 Nov; 139():18-27. PubMed ID: 30217788
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics.
    Katsanos KH; Papadakis KA
    Gut Liver; 2017 Jul; 11(4):455-463. PubMed ID: 28486793
    [TBL] [Abstract][Full Text] [Related]  

  • 94. miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8.
    Yin T; Liu MM; Jin RT; Kong J; Wang SH; Sun WB
    Pathol Res Pract; 2019 Jun; 215(6):152406. PubMed ID: 30967300
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.
    Motilva V; Talero E; Calvo JR; Villegas I; Alarcón-de-la-Lastra C; Sánchez-Fidalgo S
    Curr Pharm Des; 2008; 14(1):71-95. PubMed ID: 18220820
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.
    Rose-John S; Mitsuyama K; Matsumoto S; Thaiss WM; Scheller J
    Curr Pharm Des; 2009; 15(18):2095-103. PubMed ID: 19519447
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay.
    Li J; Ji H; Porter DC; Broude EV; Roninson IB; Chen M
    Cells; 2019 Oct; 8(10):. PubMed ID: 31590445
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhibition of Cdk8/Cdk19 Activity Promotes Treg Cell Differentiation and Suppresses Autoimmune Diseases.
    Guo Z; Wang G; Lv Y; Wan YY; Zheng J
    Front Immunol; 2019; 10():1988. PubMed ID: 31552016
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Development of Highly Potent and Selective Pyrazolopyridine Inhibitor of CDK8/19.
    Hatcher JM; Vatsan PS; Wang E; Jiang J; Gray NS
    ACS Med Chem Lett; 2021 Nov; 12(11):1689-1693. PubMed ID: 34795857
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease.
    Lv Y; Zhen C; Liu A; Hu Y; Yang G; Xu C; Lou Y; Cheng Q; Luo Y; Yu J; Fang Y; Zhao H; Peng K; Yu Y; Lou J; Chen J; Ni Y
    mSystems; 2024 Sep; 9(9):e0078324. PubMed ID: 39150251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.